McGill Thyroid Nodule Score (MTNS): "Rating the risk," a novel predictive scheme for cancer risk determination

Journal of Otolaryngology - Head and Neck Surgery

Volumn 40, Issue SUPPL. 1, 2011, Pages

  Sands, Noah B ^a   Karls, Shawn ^a   Amir, Alexander ^a   Tamilia, Michael ^a   Gologan, Olga ^b   Rochon, Louise ^b   Black, Martin J ^a   Hier, Michael P ^a   Payne, Richard J ^a  

^a Department of Otolaryngology Head and Neck Surgery ^*

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Fine needle aspiration; Risk factors for malignancy; Thyroid cancer; Thyroid ultrasonography; Thyroidectomy

Indexed keywords

THYROTROPIN;

ADULT; AGE; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER INCIDENCE; CANCER RISK; CLINICAL DECISION MAKING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOLOGY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; ETHNICITY; EVIDENCE BASED PRACTICE; FAMILY HISTORY; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; IONIZING RADIATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MCGILL THYROID NODULE SCORE; PATHOLOGIST; PHYSICAL EXAMINATION; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION EXPOSURE; RATING SCALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SURGEON; THYROID CANCER; THYROID CARCINOMA; THYROID NODULE; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

BIOPSY, FINE-NEEDLE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; QUEBEC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THYROID NEOPLASMS; THYROID NODULE;

EID: 79954550479     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2011.100098     Document Type: Article

References (69)

1. Yassa L, Cibas E, Benson C, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 2007;111:508-16. (Pubitemid 350304903)
2. Brander A, Viikinkoski P, Tuuhea J, et al. Clinical versus ultrasound examination of the thyroid gland in common clinical practice. J Clin Ultrasound 1992;20:37-42.
3. Sipos J. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid 2009;19:1363-72.
4. Hayat M, Howlader N, Reichman M, Edwards B. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007; 12:20-37. (Pubitemid 46143500)
5. Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009;18:784-91.
6. Zhu C, Zheng T, Kilfoy B, et al. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid 2009;19:1061-6.
7. Cooper D, Doherty G, Haugen B, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-42.
8. Cooper D, Doherty G, Haugen B, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214.
9. Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol 2009;117:195-202.
10. Rago T, Di Coscio G, Basolo F, et al. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hurthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) 2007;66:13-20. (Pubitemid 44952489)
11. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-53. (Pubitemid 19011971)
12. Cohen E, Tuttle R, Kraus D. Postoperative management of differentiated thyroid cancer. Otolaryngol Clin North Am 2003;36: 129-57. (Pubitemid 36384145)
13. Hay I, Bergstralh E, Goellner J, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:p. 1050-7; discussion 1057-8.
14. Tyler D, Shaha A, Udelsman R, et al. Thyroid cancer: 1999 update. Ann Surg Oncol 2000;7:376-98.
15. Tyler D, Winchester D, Caraway N, et al. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery 1994;116:1054-60. (Pubitemid 24382166)
16. Welch Dinauer C, Tuttle R, Robie D, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 1998;49:619-28. (Pubitemid 28529761)
17. Raber W, Kaserer K, Niederle B, Vierhapper H. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid 2000;10:709-12.
18. Kim E, Nam-Goong I, Gong G, et al. Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm." Korean J Intern Med 2003;18: 94-7.
19. Zaydfudim V, Feurer I, Griffin M, Phay J. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008;144:1070-7; discussion 1077-8.
20. Bonnet S, Hartl D, Leboulleux S, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 2009;94: 1162-7.
21. Boelaert K, Horacek J, Holder R, et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006;91:4295-301. (Pubitemid 44833401)
22. Haymart M, Repplinger D, Leverson G, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008;93:809-14. (Pubitemid 351398557)
23. Richardson D. Exposure to ionizing radiation in adulthood and thyroid cancer incidence. Epidemiology 2009;20:181-7.
24. Thompson D, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res 1994; 137(2 Suppl):S17-67.
25. Shore R, Hildreth N, Dvoretsky P, et al. Thyroid cancer among persons given x-ray treatment in infancy for an enlarged thymus gland. Am J Epidemiol 1993;137:1068-80. (Pubitemid 23191074)
26. Sont W, Zielinski J, Ashmore J, et al. First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada. AmJ Epidemiol 2001;153:309-18. (Pubitemid 32144555)
27. Wang J, Zhang L, Li B, et al. Cancer incidence and risk estimation among medical x-ray workers in China, 1950-1995. Health Phys 2002;82:455-66.
28. Clark J, Eski S, Freeman J. Risk of malignancy in Filipinos with thyroid nodules - a matched pair analysis. Head Neck 2006;28: 427-31. (Pubitemid 43673077)
29. Bernstein L, Miu A, Monroe K, et al. Cancer incidence among Filipinos in Los Angeles County, 1972-1991. Int J Cancer 1995;63: 345-8.
30. Kus L, Shah M, Eski S, et al. Thyroid cancer outcomes in Filipino patients. Arch Otolaryngol Head Neck Surg 2010;136:138-42.
31. Spitz M, Sider J, Katz R, et al. Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981. Int J Cancer 1988;42: 549-53.
32. Parkin D, Muir C. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 1992;(120):45-173.
33. Hemminki K, Eng C, Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 2005;90:5747-53. (Pubitemid 41415486)
34. Koike E, Noguchi S, Yamashita H, et al. Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg 2001;136:334-7. (Pubitemid 32204972)
35. Niu L, Hao Y, Zhou C. [Diagnostic value of ultrasonography in thyroid lesions]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2006;41:415-8.
36. Kim E, Park C, Chung W, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 2002;178:687-91. (Pubitemid 34182827)
37. Kim J, Lee C, Kim S, et al. Radiologic and pathologic findings of nonpalpable thyroid carcinomas detected by ultrasonography in a medical screening center. J Ultrasound Med 2008;27:215-23.
38. Moon W, Jung S, Lee J, et al. Benign and malignant thyroid nodules: US differentiation - multicenter retrospective study. Radiology 2008;247:762-70.
39. Park M, Shin J, Han B, et al. Sonography of thyroid nodules with peripheral calcifications. J Clin Ultrasound 2009;37:324-8.
40. Rago T, Vitti P, Chiovato L, et al. Role of conventional ultrasonography and color flow-Doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol 1998;138: 41-6.
41. Cerbone G, Spiezia S, Colao A, et al. Power Doppler improves the diagnostic accuracy of color Doppler ultrasonography in cold thyroid nodules: follow-up results. Horm Res 1999;52:19-24. (Pubitemid 30071924)
42. Solbiati L, Osti V, Cova L, Tonolini M. Ultrasound of thyroid, parathyroid glands and neck lymph nodes. Eur Radiol 2001;11: 2411-24. (Pubitemid 33114892)
43. Alexander E, Marqusee E, Orcutt J, et al. Thyroid nodule shape and prediction of malignancy. Thyroid 2004;14:953-8. (Pubitemid 39612914)
44. Stulak J, Grant C, Farley D, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 2006;141:489-94; discussion 494-96.
45. Ohba K, Nishizawa S, Matsushita A, et al. High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodexyglucose positron emission tomography in relatively young healthy subjects: results of 3-year follow-up. Endocr J 2010; 57:395-401. Epub 2010 Feb 17.
46. Chu Q, Connor M, Lilien D, et al. Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. Am Surg 2006;72:272-5. (Pubitemid 351837710)
47. Kim T, Kim W, Ryu J, et al. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005;115:1074-8. (Pubitemid 40777005)
48. Kang K, Kim S, Kang H, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003;88: 4100-4. (Pubitemid 37153705)
49. Kwak J, Kim E, Yun M, et al. Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation. AJR Am J Roentgenol 2008;191:598-603.
50. Alexander E, Hurwitz S, Heering J, et al. Natural history of benign solid and cystic thyroid nodules. Ann Intern Med 2003;138:315-8. (Pubitemid 36205928)
51. Papini E, Petrucci L, Guglielmi R, et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998;83:780-3. (Pubitemid 28496445)
52. Brauer V, Eder P, Miehle K, et al. Interobserver variation for ultrasound determination of thyroid nodule volumes. Thyroid 2005;15:1169-75. (Pubitemid 41720724)
53. Tuttle R, Lemar H, Burch H. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998;8: 377-83. (Pubitemid 28252418)
54. Baloch Z, Fleisher S, LiVolsi V, Gupta P. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26:41-4.
55. Giorgadze T, Rossi E, Fadda G, et al. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Diagn Cytopathol 2004;31:307-12.
56. Raparia K, Min S, Mody D, et al. Clinical outcomes for "suspicious" category in thyroid fine-needle aspiration biopsy: patient's sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med 2009;133:787-90.
57. Pu R, Yang J, Wasserman P, et al. Does Hurthle cell lesion/ neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol 2006;34: 330-4.
58. McHenry C, Thomas S, Slusarczyk S, Khiyami A. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery 1999;126:798-802; discussion 802-4.
59. Greaves T, Olvera M, Florentine B, et al. Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer 2000;90: 335-41. (Pubitemid 32011844)
60. Goldstein R, Netterville J, Burkey B, Johnson J. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg 2002;235:656-62; discussion 662-4.
61. Kelman A, Rathan A, Leibowitz J, et al. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. Thyroid 2001;11:271-7. (Pubitemid 32298425)
62. Carpi A, Ferrari E, Toni M, et al. Needle aspiration techniques in preoperative selection of patients with thyroid nodules: a longterm study. J Clin Oncol 1996;14:1704-12. (Pubitemid 26134230)
63. Mai K, Yazdi H, Perkins D, et al. Papillary thyroid carcinoma and related thyroid neoplastic lesions: a light microscopic study with emphasis on nuclear changes. Tumori 2000;86:238-49. (Pubitemid 30470745)
64. Sack M, Astengo-Osuna C, Lin B, et al. HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod Pathol 1997;10:668-74. (Pubitemid 27321757)
65. Cheung C, Ezzat S, Freeman J, et al. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 2001;14:338-42.
66. Nikiforova M, Nikiforov Y. Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009;19:1351-61.
67. Rowe L, Bentz B, Bentz J. Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules. Cytojournal 2006;3:10.
68. Pizzolanti G, Russo L, Richiusa P, et al. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Thyroid 2007;17:1109-15. (Pubitemid 350207747)
69. Haugen B, Woodmansee W, McDermott M. Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours. Clin Endocrinol (Oxf) 2002;56:281-90. (Pubitemid 34310003)